Induction of apoptosis by S-nitrosoglutathione and Cu2+ or Ni2+ ion through modulation of bax, bad, and bcl-2 proteins in human colon adenocarcinoma cells

Molecular Carcinogenesis

Volumn 26, Issue 3, 1999, Pages 201-211

  Ho, Yuan Soon ^a   Liu, Hsu Ling ^a   Duh, Jiing Shium ^a   Chen, Rong Jane ^a   Ho, Wei Lu ^a   Jeng, Jiiang Huei ^b   Wang, Ying Jan ^c   Lin, Jen Kun ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NONE

Author keywords

Apoptosis; Bad; Bax; Bcl 2; Copper ion; Nitric oxide

Indexed keywords

COPPER ION; NICKEL; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2; S NITROSOGLUTATHIONE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COLON ADENOCARCINOMA; COLON CARCINOMA; DNA DAMAGE; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROFLUOROMETRY;

ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CATIONS, DIVALENT; COLONIC NEOPLASMS; COPPER; GLUTATHIONE; HT29 CELLS; HUMANS; NICKEL; NITRIC OXIDE; NITROSO COMPOUNDS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; S-NITROSOGLUTATHIONE; SPECTROPHOTOMETRY;

EID: 0032705798     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199911)26:3<201::AID-MC9>3.0.CO;2-K     Document Type: Article

References (71)

1. Sarih M, Souvannavong V, Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 1993;191:503-508.
2. Albina JE, Cui S, Mateo RB, et al. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993;11:5080-5085.
3. Cui S, Reichner JS, Mateo RB, et al. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms. Cancer Res 1994;54:2462-2467.
4. Ankarcrona M, Dypbukt JM, Brne B, et al. Interleukine-1-β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 1994;213:172-177.
5. Ho YS, Wang YJ, Lin JK. Induction of p53and p21/WAF1/ CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog 1996;16: 20-31.
6. Forrester K, Ambs S, Lupold SE, et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase(NOS2) expression by wild-type p53. Proc Natl Acad Sci USA 1996;93:2442-2447.
7. Fehsel K, Kroncke K-D, Meyer KL, et al. Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 1995;155: 2858-2865.
8. Geng YJ, Hellstrand K, Wennmalm A, et al. Apoptosis death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha. Cancer Res 1996;56:866-874.
9. Meβmer UK, Ankarcrona M, Nicotera P, et al. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355: 23-26.
10. Ambs S, Hussain SP, Harris CC. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 1997;11:443-448.
11. Thomsen LL, Lawton FG, Knowles RG, et al. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994;54:1352-1354.
12. Thomsen LL, Miles DW, Happerfield L, et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-44.
13. Cobbs CS, Brenman JE, Aldape KD, et al. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995;55:727-730.
14. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54: 4855-4878.
15. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992;89: 7674-7677.
16. Gaston B, Reilly J, Drazen JM, et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 1993;90:10957-10961.
17. Clancy RM, Levartovsky D, Leszcynskapiziak J, et al. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: Evidence for S-nitrosoglutathione as a bioactive intermediary. Proc Natl Acad Sci USA 1994;91:3680-3684.
18. Kowaluk EA, Fung HL. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther 1990;255: 1256-1264.
19. 2+ of nitric oxide release from S-nitrosothiols (RSNO). J C hem Soc Perkin T 1995;2:741-745.
20. + as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO). J Chem Soc Perkin T 1996;2: 481-487.
21. Wink DA, Nims RW, Darbyshire JF, et al. Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/ O2 reaction. Chem Res Toxicol 1994;7:519-525.
22. 2 reaction. Chem Res Toxicol 1993;6:23-27.
23. Kharitonov VG, Sundquist AR, Sharma VS. Kinetics of the nitric oxide autoxidation in aqueous solution. J Biol Chem 1994;269:5881-5883.
24. Mayer B, Klatt P, Werner ER, et al. Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem 1995;270:655-659.
25. Jensen DE, Belka GK. Enzymatic denitrosation of 1,3-dimethyl-2-cyano-1-nitrosoguanidine in rat liver cytosol and the fate of the immediate product S-nitrosoglutathione. Biochem Pharmacol 1997;53(9):1279-1295.
26. Mayer B, Schrammel A, Klatt P, et al. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence of glutathione and possible role of S-nitrosation. J Biol Chem 1995;270:17355-17360.
27. Hart TW. Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione. Tetrahedron Lett 1985;26:2013-2016.
28. Wang YJ, Ho YS, Pan MH, et al. Mechanisms of cell death induced by nitric oxide and peroxynitrite in Calu-1 cells. Environmental Toxicology and Pharmacology 1998;6: 35-44.
29. Singh SP, Wishnok JS, Keshive M, et al. The chemistry of the S-nitrosothione/glutathione system. Proc Natl Acad Sci USA 1996;93:14428-14433.
30. Semple TU, Quinn LA, Woods LK, et al. Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxic model. Cancer Res 1978;38:1345-1355.
31. Rodrigues NR, Rowan A, Smith MEF, et al. JV, and Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-7559.
32. Aden DP, Fogel A, Plotkin S, et al. Controlled synthesis of HBs Ag in a differentiated human liver carcinoma-derived cell line. Nature 1979;282:615-616.
33. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980;209:497-499.
34. Darlington GJ, Kelly JH, Buffone GJ. Growth and hepatos-pecific gene expression of human hepatoma cells a defined medium. In Vitro Cell Dev Biol 1987;23:349-354.
35. Bressac B, Galvin KM, Liang TJ, et al. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:1973-1977.
36. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediate from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988;141:2407-2412.
37. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Application to mammalian blood and other tissue. Anal Biochem 1969;27:502-522.
38. Kroneck P. Models for the electron pharmagnetic resonance nondetectable copper in "blue oxidase." A binuclear copper (II) complex with oxidized glutathione. Journal of the American Chemical Society 1975;97:3839-3841.
39. Ho YS, Lee HM, Mou TC, et al. Suppression of nitric oxide-induced apoptosis by L-N-acetylcysteine through modulation of glutathione, bcl-2, and bax protein levels. Mol Carcinog 1997;19:101-113.
40. Friedman HS, Colvin OM, Griffth OW, et al. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion. J Natl Cancer Inst 1989;81: 524-527.
41. Celli A, Que FG, Gores GJ, et al. Glutathione depletion is associated with decreased bcl-2 expression and increased apoptosis in cholangiocytes. Am J Physiol 1998;275: G749-G757.
42. Nussler AK, Billar TR. Inflammation immunoregulation and inducible nitric oxide synthase. J Leukoc Biol 1993;54: 171-178.
43. Mirvish SS. Roles of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposure to NOC. Cancer Lett 1995;93(1):17-48.
44. Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: A review. Mutat Res 1995;339:73-89.
45. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 1996;313:17-29.
46. Mëlková Z, Lee SB, Rodriguez D, et al. Bcl-2 prevents nitric oxide-mediated apoptosis and poly (ADP-ribose) polymerase cleavage. FEBS Lett 1997;403:273-278.
47. Xie K, Wang Y, Huang S, et al. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with down regulation of Bcl-2. Oncogene 1997;15:771-779.
48. Brockhaus F, Brüne B. U937 apoptotic cell death by nitric oxide: bcl-2 down regulation and caspase activation. Exp Cell Res 1998;238:33-41.
49. Mathews WR, Keer SW. Biological activity of S-nitrosothiols: The role of nitric oxide. J Pharmacol Exp Ther 1994;267: 1529-1537.
50. Gorren ACF, Schrammel A, Schmidt K, et al. Decomposition of S-nitrosoglutathione in the presence of copper ions and glutathione. Arch Biochem Bioph 1996;330:219-228.
51. Barnes PJ. Nitric oxide and asthma. Res Immunol 1995; 146(9):698-702.
52. Chamulitrat W, Blazka ME, Jordan SJ, et al. Tumor necrosis factor-alpha and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. Life Sci 1991;57:2273-2280.
53. Laskin DL. Sinusoidal lining cells and hepatotoxicity. Toxicol Pathol 1996;24:112-118.
54. Tian L, Noelle RJ, Lawrence DA. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 1995;25:305-309.
55. Lawrence DA, McCabe MJJr. Immune modulation by toxic metals. In: Goyer RA, Klaasen CD, Waalkes MP, editors. Metal toxicology. San Diego: Academic Press; 1995. p 305-337.
56. Knowles RG, Moncada S. Nitric syntheses in mammals. Biochem J 1994;298:249-258.
57. Hostynek JJ, Hinz RS, Lorence CR, et al. Metals and the skin. Crit Rev Toxicol 1993;23:171-235.
58. Costa M. Molecular mechanisms of nickels carcinogenesis. Annu Rev Pharmacol 1991;31:321-337.
59. Kapsenberg ML, Wierenga EA, Stiekema FEM, et al. Th1 lymphokine production profiles of nickle-specific CD4+ T-lymphocyte clones from nickel contact allergic and nonallergic individuals. J Invest Dermatol 1992;98: 59-63.
60. Loeffler DA, LeWitt PA, Juneau PL, et al. Increase regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 1996;783(2):265-274.
61. Merad-Boudia M, Nicole A, Santiard-Baron D, et al. Mitochondria impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: Relevance to Parkinson's disease. Biochem Pharmacol 1998;56:645-655.
62. Froissard P, Herv M, Duval D. Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells. Eur J Pharmacol 1997;326:93-99.
63. Riederer P, Sofic E, Rauch WD, et al. Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J Neurochem 1989;52:512-520.
64. Di Monte DA, Chan P, Sandy MS. Glutathione in Parkinson's disease: A link between oxidative stress and mitochondrial damage? Ann Neurol 1992;32:S111-S115.
65. Heneka MT, Löschmann Peter-A, Gleichmann M, et al. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-α/lipopolysaccharide. J Neurochem 1998;71:88-94.
66. Estévez AG, Spear N, Anthony Thompson J, et al. Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotropic factor. J Neurosci 1998;18(10):3708-3714.
67. Estévez AG, Spear N, Manuel SM, et al. Nitric oxide and superoxide contribute to tumor neuron apoptosis induced by tropic factor deprivation. J Neurosci 1998;18(3):923-931.
68. Leist M, Nicotera P. Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res 1998;239:183-201.
69. Ralmer RMJ, Moncada S, Radomski MW. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and postacyclin in platelets. Br J Pharmacol 1987;92:181-187.
70. Gordge MP, Meyer DJ, Hothersall J, et al. Copper chelation-induced reduction of the biological activity of S-nitrosothiols. Br J Pharmacol 1995;114:1083-1089.
71. Gordge MP, Hothersall JS, Neild GH, et al. Role of a copper(l)-dependent enzyme in the antiplatelet action of S-nitrosoglutathions. Br J Pharmacol 1996;118:1083-1089.